To this end the accountant must analyse the financial statements of the previous three years as well as the liquidity plan of the coming three years with regard to the effect of the rebates on the financial situation of the applicant. The accountant must verify the calculations and submissions concerning the key business indicators and the revenue and liquidity situation. Against this background the accountant must assess whether the additional burden introduced by the price freeze is so significant that the financial capacities of the undertaking are in danger in the short to medium term.
24 3. DESCRIPTION OF THE MEASURE › 3.2. Exemption from the manufacturer's rebate on pharmaceutical products under German law, Decision_act (EU) 2015/1300
In forcesince 27 Mar 2015